UMC119-01

N/A

Report date: 2025/01/07 15:46:22

Base Information

Drug NameUMC119-01
Drug Alias NameHuman Umbilical Cord Derived-Mesenchymal Stem Cells (Meridigen Biotech)人脐带源间充质干细胞 (宣捷细胞生物)UMC119-01hUC-MSCs (Meridigen Biotech)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsBronchopulmonary Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeridigen Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeridigen Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsBronchopulmonary Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A